Ma Yinglong: Subsidiary Obtains Drug Registration Certificate for Sodium Bromfenac Eye Drops.

Ma Yinglong announced that its subsidiary, Jiangxi Ma Yinglong Meikang Pharmaceutical Co., Ltd., has received the "Drug Registration Certificate" issued by the National Medical Products Administration for Sodium Bromofenac Eye Drops. Sodium bromofenac eye drops are used for the symptomatic treatment of inflammatory diseases of the external eye and anterior eye [conjunctivitis, keratitis, postoperative inflammation]. This approval will help to enrich the company's ophthalmic product line.